Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Public ClinicalTrials.gov record NCT02959970. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Phase 4 Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety, tolerability, pharmacokinetics (PK) and efficacy of ACZONE Gel, 7.5% administered topically once-daily for 12 weeks in 9 to 11 year-olds with acne vulgaris.
Study identification
- NCT ID
- NCT02959970
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2016 (Actual)
- Primary completion
- Mar 9, 2018 (Actual)
- Completion
- Mar 9, 2018 (Actual)
- Last update posted
- Mar 3, 2020
2016 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kirklin Clinic | Birmingham | Alabama | 35233 | — |
| Center for Dermatology Clinical Research | Fremont | California | 94538 | — |
| Quest Dermatology Research | Northridge | California | 91324 | — |
| Southern California Dermatology | Santa Ana | California | 92701 | — |
| Redwood Family Dermatology | Santa Rosa | California | 95401 | — |
| Center for Clinical and Cosmetic Research | Aventura | Florida | 33180 | — |
| Baumann Cosmetic and Research Institute | Miami Beach | Florida | 33137 | — |
| Dermresearch, PLLC | Louisville | Kentucky | 40217 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Saint Louis University Dermatology | St Louis | Missouri | 63104 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Skin Specialty Dermatology | New York | New York | 10155 | — |
| Health Sciences/Department of Dermatology | Winston-Salem | North Carolina | 27106 | — |
| KGL Skin Study Center | Broomall | Pennsylvania | 19008 | — |
| Department of Dermatology, UPCII | Hershey | Pennsylvania | 17033 | — |
| Arlington Research Center, Inc. | Arlington | Texas | 76011 | — |
| DermResearch, LLC | Austin | Texas | 78759 | — |
| University of Texas Medical School at Houston | Houston | Texas | 77030 | — |
| Austin Institute for Clinical Research, Inc. | Pflugerville | Texas | 78660 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02959970, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02959970 live on ClinicalTrials.gov.